Holland, MI, United States of America

F Gregory Spence

This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: F Gregory Spence: Innovator in Pharmaceutical Chemistry

Introduction

F Gregory Spence is a notable inventor based in Holland, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for synthesizing important compounds.

Latest Patents

Spence holds 2 patents, with his latest focusing on a process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines. This innovative process describes a method for preparing a stereospecific (S)-3-amino-1-substituted pyrrolidine, which serves as a key intermediate in the synthesis of quinolone and naphthyridone antibacterial agents. The process begins with inexpensive L-aspartic acid, which is transformed into the desired (S)-3-aminopyrrolidine through a novel, high-yield transformation of a substituted aziridine.

Career Highlights

F Gregory Spence has worked at Warner-Lambert Company, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of effective antibacterial agents, showcasing his expertise in the field.

Collaborations

Throughout his career, Spence has collaborated with notable colleagues, including Tung Van Le and James N Wemple. These partnerships have further enhanced his contributions to pharmaceutical innovations.

Conclusion

F Gregory Spence is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in antibacterial agent development. His innovative processes and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…